Patents by Inventor Jeffrey S. Bland

Jeffrey S. Bland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100069422
    Abstract: Methods and compositions that can be used to promote bone and joint health through amelioration, stabilization and repair of damage associated with various pathophysiological conditions are disclosed.
    Type: Application
    Filed: November 25, 2009
    Publication date: March 18, 2010
    Applicant: METAPROTEOMICS, LLC
    Inventors: Matthew L. Tripp, Veera Konda, Anu Desai, Amy J. Hall, Jeffrey S. Bland
  • Patent number: 7666449
    Abstract: The invention provides hops (Humulus lupulus) extracts or derivatives thereof for use in treating a patient prophylactically and/or therapeutically for ulcerogenic-type disorders of the stomach and/or intestines. The ulcerogenic disorders can be of the type chemically induced, environmentally-induced, infection-induced, and/or stress-induced. The invention also provides a pharmaceutical composition comprising an active amount of hops extracts or derivatives thereof, in combination with an analgesic compound and/or an anti-inflammatory compound. The invention further provides for use of hops extracts or derivatives thereof, significantly reducing and/or therapeutically treating ulcerogenic-type disorders of the stomach and/or intestines.
    Type: Grant
    Filed: February 15, 2006
    Date of Patent: February 23, 2010
    Assignee: Metaproteomics, LLC
    Inventors: John G. Babish, Matthew L. Tripp, Jeffrey S. Bland, Terrence Howell, Gary K. Darland, Robert H. Lerman, Daniel O. Lukaczer
  • Publication number: 20090155382
    Abstract: Compositions and methods for enhancing heavy metal detoxification are described. The compositions and methods described provide enhanced activity of key detoxification systems including that the induction of phase II detoxification enzymes, such as glutathione S-transferases (GSTs), and NADPH quinone reductase (NQO1) activity.
    Type: Application
    Filed: February 13, 2008
    Publication date: June 18, 2009
    Applicant: Metaproteomics, LLC
    Inventors: Matthew L. Tripp, Veera Konda, Amy Hall, Anu Desai, Jeffrey S. Bland
  • Publication number: 20090118373
    Abstract: A natural formulation of compounds isolated or derived from hops which inhibit the activity of cyclooxygenase-2 (COX-2) and/or 5-lipoxygenase (5-LOX) is disclosed. The hops formulations may be administered to a mammal to treat or inhibit a pathological condition associated with the activity of COX-2 and/or 5-LOX in such a mammal.
    Type: Application
    Filed: June 10, 2004
    Publication date: May 7, 2009
    Inventors: Matthew L. Tripp, Gary K. Darland, Mark Fuller, John G. Babish, Jeffrey S. Bland
  • Publication number: 20090087512
    Abstract: The invention provides an encapsulation composition comprising a fraction isolated or derived from hops encapsulated in a matrix selected from at least one of the group consisting of a phytosterol and a cyclodextrin.
    Type: Application
    Filed: May 14, 2004
    Publication date: April 2, 2009
    Inventors: Matthew L. Tripp, Deanna Minich, Tracey Irving, Revathy Ramachandran, Jeffrey S. Bland, Peter Nelson
  • Publication number: 20080248131
    Abstract: Botanical compounds to modulate kinase activity are disclosed. The compounds and methods disclosed also inhibit expression of COX-2, inhibit synthesis o prostaglandins selectively in target cells, and inhibit inflammatory response selectively. The compositions contain at least one fraction isolated or derived from hops or Acacia.
    Type: Application
    Filed: August 9, 2006
    Publication date: October 9, 2008
    Applicant: Metaproteomics, LLC
    Inventors: Matthew L. Tripp, John G. Babish, Jeffrey S. Bland, Amy J. Hall, Veera Konda, Anu Desai
  • Patent number: 7431948
    Abstract: A natural formulation of compounds that would to modulate inflammation is disclosed. The formulation would also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively in target cells. The compositions containing at least one fraction isolated or derived from hops. Other embodiments relate to combinations of components, including at least one fraction isolated or derived from hops, tryptanthrin and conjugates thereof, rosemary, an extract or compound derived from rosemary, a triterpene species, or a diterpene lactone or derivatives or conjugates thereof.
    Type: Grant
    Filed: April 12, 2006
    Date of Patent: October 7, 2008
    Assignee: Metaproteomics, LLC
    Inventors: Matthew L. Tripp, John G. Babish, Jeffrey S. Bland, Gary K. Darland, Robert Lerman, Daniel O. Lukaczer, DeAnn J. Liska, Terrence Howell
  • Publication number: 20080242690
    Abstract: Methods and compositions that can be used to promote bone and joint health through amelioration, stabilization and repair of damage associated with various pathophysiological conditions are disclosed.
    Type: Application
    Filed: March 14, 2008
    Publication date: October 2, 2008
    Inventors: Matthew L. Tripp, Veera Konda, Anu Desai, Amy J. Hall, Jeffrey S. Bland
  • Patent number: 7270835
    Abstract: A natural formulation of compounds that would to modulate inflammation is disclosed. The formulation would also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively in target cells. The compositions containing at least one fraction isolated or derived from hops. Other embodiments relate to combinations of components, including at least one fraction isolated or derived from hops, tryptanthrin and conjugates thereof, rosemary, an extract or compound derived from rosemary, a triterpene species, or a diterpene lactone or derivatives or conjugates thereof.
    Type: Grant
    Filed: October 20, 2003
    Date of Patent: September 18, 2007
    Assignee: Metaproteomics, LLC
    Inventors: Matthew L. Tripp, John G. Babish, Jeffrey S. Bland, Gary K. Darland, Robert Lerman, Daniel O. Lukaczer, DeAnn J. Liska, Terrence Howell
  • Publication number: 20040219240
    Abstract: The invention provides hops (Humulus lupulus) extracts or derivatives thereof for use in treating a patient prophylactically and/or therapeutically for ulcerogenic-type disorders of the stomach and/or intestines. The ulcerogenic disorders can be of the type chemically induced, environmentally-induced, infection-induced, and/or stress-induced. The invention also provides a pharmaceutical composition comprising an active amount of hops extracts or derivatives thereof, in combination with an analgesic compound and/or an anti-inflammatory compound. The invention further provides for use of hops extracts or derivatives thereof, significantly reducing and/or therapeutically treating ulcerogenic-type disorders of the stomach and/or intestines.
    Type: Application
    Filed: February 5, 2004
    Publication date: November 4, 2004
    Inventors: John G. Babish, Matthew L. Tripp, Jeffrey S. Bland, Terrence Howell, Gary K. Darland, Robert H. Lerman, Daniel O. Lukaczer
  • Publication number: 20040220118
    Abstract: Medical compositions and methods using same to nutritionally support balance of bodily processes are disclosed. A medical composition to nutritionally support balance of bodily processes involving S-adenosylmethionine is disclosed.
    Type: Application
    Filed: December 11, 2003
    Publication date: November 4, 2004
    Inventors: Jeffrey S. Bland, DeAnn J. Liska, Kim Carleton Krumhar, Matthew L. Tripp, Gary K. Darland, Robert H. Lerman, Daniel O. Lukaczer
  • Publication number: 20040151792
    Abstract: A natural formulation of compounds that would to modulate inflammation is disclosed. The formulation would also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively in target cells. The compositions containing at least one fraction isolated or derived from hops. Other embodiments relate to combinations of components, including at least one fraction isolated or derived from hops, tryptanthrin and conjugates thereof, rosemary, an extract or compound derived from rosemary, a triterpene species, or a diterpene lactone or derivatives or conjugates thereof.
    Type: Application
    Filed: October 20, 2003
    Publication date: August 5, 2004
    Inventors: Matthew L. Tripp, John G. Babish, Jeffrey S. Bland, Gary K. Darland, Robert Lerman, Daniel O. Lukaczer, DeAnn J. Liska, Terrence Howell
  • Publication number: 20040115290
    Abstract: A natural formulation of compounds that would to modulate inflammation is disclosed. The formulation would also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively in target cells. The compositions containing at least one fraction isolated or derived from hops.
    Type: Application
    Filed: June 18, 2003
    Publication date: June 17, 2004
    Inventors: Matthew L. Tripp, John G. Babish, Jeffrey S. Bland, Gary K. Darland, Robert Lerman, Daniel O. Lukaczer, DeAnn J. Liska, Terrence Howell
  • Publication number: 20040086580
    Abstract: A natural formulation of compounds that would to modulate inflammation is disclosed. The formulation would also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively in target cells. The compositions containing at least one fraction isolated or derived from hops. Other embodiments relate to combinations of components, including at least one fraction isolated or derived from hops, tryptanthrin and conjugates thereof, rosemary, an extract or compound derived from rosemary, a triterpene species, or a diterpene lactone or derivatives or conjugates thereof.
    Type: Application
    Filed: June 18, 2003
    Publication date: May 6, 2004
    Inventors: Matthew L. Tripp, John G. Babish, Jeffrey S. Bland, Gary K. Darland, Robert Lerman, Daniel O. Lukaczer, DeAnn J. Liska, Terrence Howell
  • Publication number: 20030190381
    Abstract: Medical compositions and methods using same to nutritionally support balance of bodily processes are disclosed. A medical composition to nutritionally support balance of bodily processes involving S-adenosylmethionine is disclosed.
    Type: Application
    Filed: January 27, 2003
    Publication date: October 9, 2003
    Inventors: Jeffrey S. Bland, DeAnn J. Liska, Kim C. Krumhar, Matthew Tripp, Gary K. Darland, Robert Lerman, Daniel O. Lukaczer
  • Patent number: 6602517
    Abstract: The present invention provides dietary supplements, medical foods and methods effective to ameliorate at least one of the symptoms, preferably all of the symptoms, of an inflammation-related disease. The dietary supplements of the present invention include rosemary, curcumin and at least one component selected from the group consisting of quercetin and rutin. The medical foods of the present invention include include rosemary and at least one component selected from the group consisting of curcumin, quercetin and rutin. The medical foods of the present invention also include macronutrients. The methods of the present invention include the step of administering to a person suffering from an inflammation-related disease an effective amount of a dietary supplement or medical food of the present invention.
    Type: Grant
    Filed: January 29, 2001
    Date of Patent: August 5, 2003
    Assignee: Metagenics, Inc.
    Inventors: Gary K. Darland, Daniel O. Lukaczer, DeAnn J. Liska, Tracey A. Irving, Jeffrey S. Bland
  • Publication number: 20020192310
    Abstract: A medical composition to nutritionally support hormone balance by promoting estrogen metabolism and increasing its excretion is disclosed. Nutritional support with the medical composition results in improvement in symptoms associated with hormone imbalance. Quality-of-life data and steroid hormone markers also shows improvement over the course of administration of the medical composition.
    Type: Application
    Filed: January 23, 2002
    Publication date: December 19, 2002
    Inventors: Jeffrey S. Bland, DeAnn J. Liska, Matthew Tripp, Gary K. Darland, Daniel O. Lukaczer, Robert Lerman
  • Publication number: 20020051826
    Abstract: The present invention provides dietary supplements, medical foods and methods effective to ameliorate at least one of the symptoms, preferably all of the symptoms, of an inflammation-related disease. The dietary supplements of the present invention include rosemary, curcumin and at least one component selected from the group consisting of quercetin and rutin. The medical foods of the present invention include include rosemary and at least one component selected from the group consisting of curcumin, quercetin and rutin. The medical foods of the present invention also include macronutrients. The methods of the present invention include the step of administering to a person suffering from an inflammation-related disease an effective amount of a dietary supplement or medical food of the present invention.
    Type: Application
    Filed: January 29, 2001
    Publication date: May 2, 2002
    Applicant: HealthComm International, Inc.
    Inventors: Gary K. Darland, Daniel O. Lukaczer, DeAnn J. Liska, Tracey A. Irving, Jeffrey S. Bland
  • Patent number: 6352712
    Abstract: The present invention provides dietary supplements, medical foods and methods effective to ameliorate at least one of the symptoms, preferably all of the symptoms, of a fatigue-related syndrome, such as fibromyalgia. The dietary supplements of the present invention include rosemary, curcumin and at least one component selected from the group consisting of quercetin and rutin. The medical foods of the present invention include rosemary, at least one macronutrient selected from the group consisting of protein, carbohydrate and fat, and at least one member of the group consisting of quercetin, curcumin and rutin. The methods of the present invention include the step of administering to a person suffering from a fatigue-related syndrome an effective amount of a dietary supplement or medical food of the present invention.
    Type: Grant
    Filed: April 30, 1999
    Date of Patent: March 5, 2002
    Inventors: Daniel O. Lukaczer, Gary K. Darland, DeAnn J. Liska, Tracey A. Irving, Jeffrey S. Bland
  • Publication number: 20020025310
    Abstract: A dietary supplement for promoting healthy joints and joint tissues is disclosed. The dietary supplement comprises a member selected from the group consisting of niacinamide, niacin, and mixtures thereof and an antioxidant nutrient. Illustrative antioxidant nutrients include N-acetylcysteine, lipoic acid, coenzyme Q10, vitamin E, carotenoids, and zinc. The dietary supplement supports optimal function and health of joints and joint tissues by interrupting a cascade of events involving reactive oxygen species, cytokines, and poly(ADP-ribose) synthetase, which self-amplifying, positive feed-forward cycle is inversely correlated with joint tissue integrity. A method for promoting healthy joints and joint tissues is also described.
    Type: Application
    Filed: February 2, 2001
    Publication date: February 28, 2002
    Inventor: Jeffrey S. Bland